documents: FDA-2010-P-0614-0017
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2010-P-0614-0017 | FDA | FDA-2010-P-0614 | Tab 14 - "FDA Clinical Review for NADA 22-353" dated August 5, 2009 (Relevant Pages) - [Sidley Austin, LLP - (Mutual Pharmaceutical Company, Inc.) - Supplement] | Supporting & Related Material | SUP-Supplement (Supporting and Related Material) | 2011-01-20T05:00:00Z | 2011 | 1 | 2011-01-20T17:34:12Z | 0 | 0 | 0900006480bc1b48 |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref